CD155 is expressed at low levels in a number of cell types of epithelial origin and is overexpressed in various carcinomas with epithelial and neurological origins, including colorectal carcinoma (17), breast carcinoma, neuroblastoma and glioblastoma (18,19). This evidence concerns the gene PVR and glioblastoma.